RhumbLine Advisers’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Buy |
54,498
+21,196
| +64% | +$107K | ﹤0.01% | 3045 |
|
|
2025
Q1 | $188K | Buy |
33,302
+7,030
| +27% | +$39.7K | ﹤0.01% | 3130 |
|
|
2024
Q4 | $228K | Buy |
26,272
+3,817
| +17% | +$33.1K | ﹤0.01% | 3123 |
|
|
2024
Q3 | $156K | Sell |
22,455
-530
| -2% | -$3.67K | ﹤0.01% | 3345 |
|
|
2024
Q2 | $143K | Buy |
+22,985
| New | +$143K | ﹤0.01% | 3395 |
|